EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical Application

Asmaa Ibrahim, Mostafa Jahanifar, Noorul Wahab, Michael S Toss, Shorouk Makhlouf, Nehal Atallah, Ayat G Lashen, Ayaka Katayama, Simon Graham, Mohsin Bilal, Abhir Bhalerao, Shan E Ahmed Raza und 4 weitere

Modern Pathology · 2024

DOI: 10.1016/j.modpat.2023.100416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024. Verfasst von Asmaa Ibrahim und 15 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom; Department of Pathology, …. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education and Scientific Research, UK Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, artificial intelligence (AI) has demonstrated exceptional performance in mitosis identification and quantification. However, the implementation of AI in clinical practice needs to be evaluated against the existing methods. This study is aimed at assessing the optimal method of using AI-based mitotic figure scoring in breast cancer (BC). We utilized whole slide images from a large cohort of BC with extended follow-up comprising a discovery (n = 1715) and a validation (n = 859) set (Nottingham cohort). The Cancer Genome Atlas of breast invasive carcinoma (TCGA-BRCA) cohort (n = 757) was used as an external test set. Employing automated mitosis detection, the mitotic count was assessed using 3 different methods, the mitotic count per tumor area (MCT; calculated by dividing the number of mitotic figures by the total tumor area), the mitotic index (MI; defined as the average number of mitotic figures per 1000 malignant cells), and the mitotic activity index (MAI; defined as the number of mitotic figures in 3 mm2 area within the mitotic hotspot). These automated metrics were evaluated and compared based on their correlation with the well-established visual scoring method of the Nottingham grading system and Ki67 score, clinicopathologic parameters, and patient outcomes. AI-based mitotic scores derived from the 3 methods (MCT, MI, and MAI) were significantly correlated with the clinicopathologic characteristics and patient survival (P < .001). However, the mitotic counts and the derived cutoffs varied significantly between the 3 methods. Only MAI and MCT were positively correlated with the gold standard visual scoring method used in Nottingham grading system (r = 0.8 and r = 0.7, respectively) and Ki67 scores (r = 0.69 and r = 0.55, respectively), and MAI was the only independent predictor of survival (P < .05) in multivariate Cox regression analysis. For clinical applications, the optimum method of scoring mitosis using AI needs to be considered. MAI can provide reliable and reproducible results and can accurately quantify mitotic figures in BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleKi-67 AntigenArtificial IntelligenceMitosisMitotic Index

Stichwörter der Autor:innen

algorithmartificial intelligencemitosis

Substanzen

Ki-67 Antigen

Autor:innen und Institutionen

  • Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom; Department of Pathology, Faculty of Medicine, Suez Canal University, Egypt.
  • Tissue Image Analytics Centre, University of Warwick, United Kingdom.
  • Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom; Histopathology Department, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundat…
  • Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Cellular Pathology, University Hospitals Coventry and Warwickshire NHS Trust, United Kingdom.
  • Tissue Image Analytics Centre, University of Warwick, United Kingdom. Electronic address: n.m.rajpoot@warwick.ac.uk.

Förderung

  • Ministry of Higher Education and Scientific Research
  • UK Research and Innovation

Zitieren

APA

Ibrahim, A., Jahanifar, M., Wahab, N., Toss, M. S., Makhlouf, S., Atallah, N., Lashen, A. G., Katayama, A., Graham, S., Bilal, M., Bhalerao, A., Ahmed Raza, S. E., Snead, D., Minhas, F., Rajpoot, N., & Rakha, E. (2024). Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical Application. Modern Pathology. https://doi.org/10.1016/j.modpat.2023.100416

Vancouver

Ibrahim A, Jahanifar M, Wahab N, Toss MS, Makhlouf S, Atallah N, et al. Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical Application. Modern Pathology. 2024. doi:10.1016/j.modpat.2023.100416

BibTeX
@article{Ibrahim2024,
  author = {Ibrahim, Asmaa and Jahanifar, Mostafa and Wahab, Noorul and Toss, Michael S and Makhlouf, Shorouk and Atallah, Nehal and Lashen, Ayat G and Katayama, Ayaka and Graham, Simon and Bilal, Mohsin and Bhalerao, Abhir and Ahmed Raza, Shan E and Snead, David and Minhas, Fayyaz and Rajpoot, Nasir and Rakha, Emad},
  title = {Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical Application},
  journal = {Modern Pathology},
  year = {2024},
  doi = {10.1016/j.modpat.2023.100416}
}
Kostenlos starten →